Type 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodies.

British Journal of Hospital MedicineVol. 84, No. 2 Case ReportType 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodiesNaomi Piscopo, Samuel F Soler, Simon Mifsud, Sandro VellaNaomi PiscopoDepartment of Medicine, Mater Dei Hospital, Msida, MaltaSearch for more papers by this author, Samuel F SolerDepartment of Medicine, Mater Dei Hospital, Msida, MaltaSearch for more papers by this author, Simon MifsudCorrespondence to: Simon Mifsud; E-mail Address: [email protected]Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, MaltaSearch for more papers by this author, Sandro VellaDepartment of Diabetes and Endocrinology, Mater Dei Hospital, Msida, MaltaSearch for more papers by this authorNaomi Piscopo; Samuel F Soler; Simon Mifsud; Sandro VellaPublished Online:14 Feb 2023https://doi.org/10.12968/hmed.2022.0402AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Barra S, Primo J, Goncalves Serge Bovedac H, Providência R, Grace A. Is amiodarone still a reasonable therapeutic option for rhythm control in atrial fibrillation? Rev Port Cardiol. 2022;41(9):783–789. https://doi.org/10.1016/j.repc.2021.03.019 Crossref, Medline, Google ScholarBartalena L, Bogazzi F, Chiovato L et al.. European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7(2):55–66. https://doi.org/10.1159/000486957 Crossref, Medline, Google ScholarConnolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation. 1999;100(19):2025–2034. https://doi.org/10.1161/01.cir.100.19.2025 Crossref, Medline, Google ScholarHan TS, Williams GR, Vanderpump MP. Benzofuran derivatives and the thyroid. Clin Endocrinol (Oxf). 2009;70(1):2–13. https://doi.org/10.1111/j.1365-2265.2008.03350.x Crossref, Medline, Google ScholarSuzuki N, Kawaguchi A, Yoshimura Noh J et al.. Clinical course of euthyroid subjects with positive TSH receptor antibody: how often does Graves' disease develop? J Endocr Soc. 2021;5(6):bvab042. https://doi.org/10.1210/jendso/bvab042 Crossref, Medline, Google ScholarTomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F. The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. Eur J Endocrinol. 2014;171(3):363–368. https://doi.org/10.1530/EJE-14-0267 Crossref, Medline, Google ScholarTrohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019;29(5):285–295. https://doi.org/10.1016/j.tcm.2018.09.005 Crossref, Medline, Google ScholarTsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol. 2009;25(7):421–424. https://doi.org/10.1016/s0828-282x(09)70512-4 Crossref, Medline, Google ScholarWass JAH, Arlt W, Semple RK. Oxford textbook of endocrinology and diabetes. Oxford: Oxford University Press; 2022 Google Scholar FiguresReferencesRelatedDetails 2 February 2023Volume 84Issue 2ISSN (print): 1750-8460ISSN (online): 1759-7390 Metrics History Published online 14 February 2023 Published in print 2 February 2023 Information© MA Healthcare LimitedPDF download